|
1
|
Rossi D and Zlotnik A: The biology of
chemokines and their receptors. Annu Rev Immunol. 18:217–242. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Perissinotto E, Cavalloni G, Leone F,
Fonsato V, Mitola S, Grignani G, Surrenti N, Sangiolo D, Bussolino
F, Piacibello W and Aglietta M: Involvement of chemokine receptor
4/stromal cell-derived factor 1 system during osteosarcoma tumor
progression. Clin Cancer Res. 11:490–497. 2005.PubMed/NCBI
|
|
3
|
Geminder H, Sagi-Assif O, Goldberg L,
Meshel T, Rechavi G, Witz IP and Ben-Baruch A: A possible role for
CXCR4 and its ligand, the CXC chemokine stromal cell-derived
factor-1, in the development of bone marrow metastases in
neuroblastoma. J Immunol. 167:4747–4757. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mochizuki H, Matsubara A, Teishima J,
Mutaguchi K, Yasumoto H, Dahiya R, Usui T and Kamiya K: Interaction
of ligand-receptor system between stromal-cell-derived factor-1 and
CXC chemokine receptor 4 in human prostate cancer: A possible
predictor of metastasis. Biochem Biophys Res Commun. 320:656–663.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Muller A, Homey B, Soto H, Ge N, Catron D,
Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Balabanian K, Lagane B, Infantino S, Chow
KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M and
Bachelerie F: The chemokine SDF-1/CXCL12 binds to and signals
through the orphan receptor RDC1 in T lymphocytes. J Biol Chem.
280:35760–35766. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Teicher BA and Fricker SP: CXCL12
(SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res. 16:2927–2931.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun X, Cheng G, Hao M, Zheng J, Zhou X,
Zhang J, Taichman RS, Pienta KJ and Wang J: CXCL12/CXCR4/CXCR7
chemokine axis and cancer progression. Cancer Metastasis Rev.
29:709–722. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kang H, Watkins G, Parr C, Douglas-Jones
A, Mansel RE and Jiang WG: Stromal cell derived factor-1: Its
influence on invasiveness and migration of breast cancer cells in
vitro, and its association with prognosis and survival in human
breast cancer. Breast Cancer Res. 7:R402–R410. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mukherjee D and Zhao J: The role of
chemokine receptor CXCR4 in breast cancer metastasis. Am J Cancer
Res. 3:46–57. 2013.PubMed/NCBI
|
|
11
|
Xu C, Zhao H, Chen H and Yao Q: CXCR4 in
breast cancer: Oncogenic role and therapeutic targeting. Drug Des
Dev Ther. 9:4953–4964. 2015.
|
|
12
|
Kay R, Rosten PM and Humphries RK: CD24, a
signal transducer modulating B cell activation responses, is a very
short peptide with a glycosyl phosphatidylinositol membrane anchor.
J Immunol. 147:1412–1416. 1991.PubMed/NCBI
|
|
13
|
Schabath H, Runz S, Joumaa S and Altevogt
P: CD24 affects CXCR4 function in pre-B lymphocytes and breast
carcinoma cells. J Cell Sci. 119:314–325. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Imtiyaz HZ, Williams EP, Hickey MM, Patel
SA, Durham AC, Yuan LJ, Hammond R, Gimotty PA, Keith B and Simon
MC: Hypoxia-inducible factor 2alpha regulates macrophage function
in mouse models of acute and tumor inflammation. J Clin Invest.
120:2699–2714. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Prevarskaya N, Skryma R and Shuba Y:
Calcium in tumour metastasis: New roles for known actors. Nat Rev
Cancer. 11:609–618. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Azimi I, Roberts-Thomson SJ and Monteith
GR: Calcium influx pathways in breast cancer: Opportunities for
pharmacological intervention. Br J Pharmacol. 171:945–960. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Davis FM, Kenny PA, Soo ET, van Denderen
BJ, Thompson EW, Cabot PJ, Parat MO, Roberts-Thomson SJ and
Monteith GR: Remodeling of purinergic receptor-mediated Ca2+
signaling as a consequence of EGF-induced epithelial-mesenchymal
transition in breast cancer cells. PLoS One. 6:e234642011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Azimi I and Monteith GR: Plasma membrane
ion channels and epithelial to mesenchymal transition in cancer
cells. Endocr Relat Cancer. 23:R517–R525. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McAndrew D, Grice DM, Peters AA, Davis FM,
Stewart T, Rice M, Smart CE, Brown MA, Kenny PA, Roberts-Thomson SJ
and Monteith GR: ORAI1-mediated calcium influx in lactation and in
breast cancer. Mol Cancer Ther. 10:448–460. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Motiani RK, Abdullaev IF and Trebak M: A
novel native store-operated calcium channel encoded by Orai3:
Selective requirement of Orai3 versus Orai1 in estrogen
receptor-positive versus estrogen receptor-negative breast cancer
cells. J Biol Chem. 285:19173–19183. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peters AA, Simpson PT, Bassett JJ, Lee JM,
Da Silva L, Reid LE, Song S, Parat MO, Lakhani SR, Kenny PA, et al:
Calcium channel TRPV6 as a potential therapeutic target in estrogen
receptor-negative breast cancer. Mol Cancer Ther. 11:2158–2168.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Badve S, Dabbs DJ, Schnitt SJ, Baehner FL,
Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR,
et al: Basal-like and triple-negative breast cancers: A critical
review with an emphasis on the implications for pathologists and
oncologists. Mod Pathol. 24:157–167. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Neve RM, Chin K, Fridlyand J, Yeh J,
Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, et al: A
collection of breast cancer cell lines for the study of
functionally distinct cancer subtypes. Cancer Cell. 10:515–527.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aung CS, Ye W, Plowman G, Peters AA,
Monteith GR and Roberts-Thomson SJ: Plasma membrane calcium ATPase
4 and the remodeling of calcium homeostasis in human colon cancer
cells. Carcinogenesis. 30:1962–1969. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stewart TA, Azimi I, Brooks AJ, Thompson
EW, Roberts-Thomson SJ and Monteith GR: Janus kinases and Src
family kinases in the regulation of EGF-induced vimentin expression
in MDA-MB-468 breast cancer cells. Int J Biochem Cell Biol.
76:64–74. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pereira B, Chin SF, Rueda OM, Vollan HK,
Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ,
et al: Erratum: The somatic mutation profiles of 2,433 breast
cancers refine their genomic and transcriptomic. Nat Commun.
7:119082016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Charafe-Jauffret E, Ginestier C, Monville
F, Finetti P, Adélaïde J, Cervera N, Fekairi S, Xerri L, Jacquemier
J, Birnbaum D and Bertucci F: Gene expression profiling of breast
cell lines identifies potential new basal markers. Oncogene.
25:2273–2284. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Davis FM, Azimi I, Faville RA, Peters AA,
Jalink K, Putney JW Jr, Goodhill GJ, Thompson EW, Roberts-Thomson
SJm and Monteith GR: Induction of epithelial-mesenchymal transition
(EMT) in breast cancer cells is calcium signal dependent. Oncogene.
33:2307–2316. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Azimi I, Beilby H, Davis FM, Marcial DL,
Kenny PA, Thompson EW, Roberts-Thomson SJ and Monteith GR: Altered
purinergic receptor-Ca2 signaling associated with
hypoxia-induced epithelial-mesenchymal transition in breast cancer
cells. Mol Oncol. 10:166–178. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Azimi I, Milevskiy MJG, Kaemmerer E,
Turner D, Yapa KTDS, Brown MA, Thompson EW, Roberts-Thomson SJ and
Monteith GR: TRPC1 is a differential regulator of hypoxia-mediated
events and Akt signalling in PTEN-deficient breast cancer cells. J
Cell Sci. 130:2292–2305. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hennessy BT, Gonzalez-Angulo AM,
Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS, Fridlyand J,
Sahin A, Agarwal R, Joy C, et al: Characterization of a naturally
occurring breast cancer subset enriched in
epithelial-to-mesenchymal transition and stem cell characteristics.
Cancer Res. 69:4116–4124. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Holland JD, Kochetkova M, Akekawatchai C,
Dottore M, Lopez A and McColl SR: Differential functional
activation of chemokine receptor CXCR4 is mediated by G proteins in
breast cancer cells. Cancer Res. 66:4117–4124. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Miao Z, Luker KE, Summers BC, Berahovich
R, Bhojani MS, Rehemtulla A, Kleer CG, Essner JJ, Nasevicius A,
Luker GD, et al: CXCR7 (RDC1) promotes breast and lung tumor growth
in vivo and is expressed on tumor-associated vasculature. Proc Natl
Acad Sci USA. 104:pp. 15735–15740. 2007; View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Salvucci O, Bouchard A, Baccarelli A,
Deschênes J, Sauter G, Simon R, Bianchi R and Basik M: The role of
CXCR4 receptor expression in breast cancer: A large tissue
microarray study. Breast Cancer Res Treat. 97:275–283. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Blick T, Hugo H, Widodo E, Pinto C, Mani
SA, Weinberg RA, Neve RM, Lenburg ME and Thompson EW: Epithelial
mesenchymal transition traits in human breast cancer cell lines
parallel the CD44(hi/)CD24(lo/-) stem cell phenotype in human
breast cancer. J Mammary Gland Biol Neoplasia. 15:235–252. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schindelmann S, Windisch J, Grundmann R,
Kreienberg R, Zeillinger R and Deissler H: Expression profiling of
mammary carcinoma cell lines: Correlation of in vitro invasiveness
with expression of CD24. Tumor Biol. 23:139–145. 2002. View Article : Google Scholar
|
|
40
|
Blick T, Widodo E, Hugo H, Waltham M,
Lenburg ME, Neve RM and Thompson EW: Epithelial mesenchymal
transition traits in human breast cancer cell lines. Clin Exp
Metastasis. 25:629–642. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bertran E, Caja L, Navarro E, Sancho P,
Mainez J, Murillo MM, Vinyals A, Fabra A and Fabregat I: Role of
CXCR4/SDF-1 alpha in the migratory phenotype of hepatoma cells that
have undergone epithelial-mesenchymal transition in response to the
transforming growth factor-beta. Cell Signal. 21:1595–1606. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Prat A, Parker JS, Karginova O, Fan C,
Livasy C, Herschkowitz JI, He X and Perou CM: Phenotypic and
molecular characterization of the claudin-low intrinsic subtype of
breast cancer. Breast Cancer Res. 12:R682010. View Article : Google Scholar : PubMed/NCBI
|
